Home / Olopatadine / Japan
JP ATC S01GX09 · updated 2 Nov 2026
Olopatadine shortage in Japan
Is there an Olopatadine shortage in Japan?
Yes. As of 2 Nov 2026, 3 Olopatadine products are reported short in Japan, the first since 17 Jan 2025. No return date has been given. Main reason: manufacturing problem.
Also short in Canada. All countries.
Affected products in Japan
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| JP | オロパタジン塩酸塩ドライシロップ1%「日本臓器」 limited | 日本臓器製薬 | 17 Jan 2025 | not given | Other |
| JP | オロパタジン塩酸塩OD錠5mg「サワイ」 limited | Sawai | 15 May 2025 | not given | Manufacturing problem |
| JP | オロパタジン塩酸塩OD錠2.5mg「トーワ」 limited | Towa (Pensa) | 30 May 2025 | not given | Manufacturing problem |
Source
MHLW (Ministry of Health, Labour and Welfare), supply status of prescription medicines. Official list. Prescription products under limited shipment or supply suspension (delistings excluded); one row per product.